In a recent study of patients with metastatic melanoma, PD-1 blockade was associated with an increase in the frequency of activated effector memory CD8+ T cells in the blood, as revealed by single-cell RNA sequencing after the 2nd cycle of treatment, and only in responders, strengthening the observations in our study (39). This evidence concerns the gene CD8A and metastatic melanoma.